Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Engineering the Bio/Nano Interface for Enhanced Nano-Immunotherapy
Date: Nov. 13, 2020
Time: 11:00 a.m. - 12:00 p.m.
About This Seminar
Self-assembled nanobiomaterials that are engineered to achieve specific biodistributions and mechanisms of degradation hold great promise for controlled stimulation of the immune system. Taking advantage of the morphological flexibility of self-assembled systems, we aim to mimic various structures and biochemical mechanisms of pathogens to enhance cell-selective intracellular delivery and treatment efficacy during immunotherapy. Dr. Scott and his team specifically approach this by synthesizing, assembling and optimizing in vitro and in vivo a range of nanostructures loaded with strategically selected combinations of immunostimulants to achieve controlled activation or suppression of the immune system. Dr. Scott will present some of our ongoing work in the area of novel nanobiomaterials development and interactions at the bio/nano interface, as well as recent applications of our materials for the controlled modulation of cells for a variety of therapeutic applications, including cell/organ transplantation, vaccination, and treatment of atherosclerosis, glaucoma and infectious diseases.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home ItemIn Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , home
April 19, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center (DC)
-
Home ItemIn Person Seminar: Our Mass Spectrometry Screening Studies in the Mouse and Human Hearts in Health and Disease , home
April 26, 2024, 11 a.m. | Anthony Gramolini, Ph.D., Professor, Physiology and Translational Biology and Engineering, Ted Rogers Centre for Heart Research, University of Toronto | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemIn Person Seminar: Regulation of Mitochondrial Parameters in Skeletal Muscle , home
May 3, 2024, 11:00 a.m. | Glenn Rowe, Ph.D., Associate Professor of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemPlanning the Future of Environmental Health Sciences , home
May 9, 2024, 5:30 p.m. (Reception at 5 p.m.) | Rick Woychik, Ph.D., Director, National Institute of Environmental Health Sciences, National Institutes of Health | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: Flavors in Tobacco and Nicotine Products: Science-based Regulation , home
May 10, 2024, 11:00 a.m. | Suchitra Krishnan-Sarin, Ph.D., Albert E. Kent Professor of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
Evan Scott, Ph.D.
Kay Davis Professor of Biomedical Engineering and Microbiology-Immunology in the Robert R. McCormick School of Engineering and Applied Science at Northwestern Medicine Feinberg School of Medicine